Cipher Pharmaceuticals Inc (CPH) - Total Assets
Based on the latest financial reports, Cipher Pharmaceuticals Inc (CPH) holds total assets worth CA$156.63 Million CAD (≈ $113.31 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cipher Pharmaceuticals Inc - Total Assets Trend (2004–2025)
This chart illustrates how Cipher Pharmaceuticals Inc's total assets have evolved over time, based on quarterly financial data. Also see Cipher Pharmaceuticals Inc stock valuation for the company's overall valuation and market capitalisation.
Cipher Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Cipher Pharmaceuticals Inc's total assets of CA$156.63 Million consist of 17.9% current assets and 82.1% non-current assets. Review debt load of Cipher Pharmaceuticals Inc to assess the company's total debt and financial obligations.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$7.49 Million | 4.8% |
| Accounts Receivable | CA$11.19 Million | 7.2% |
| Inventory | CA$8.18 Million | 5.2% |
| Property, Plant & Equipment | CA$569.00K | 0.4% |
| Intangible Assets | CA$71.88 Million | 46.0% |
| Goodwill | CA$17.42 Million | 11.2% |
Asset Composition Trend (2004–2025)
This chart illustrates how Cipher Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Cipher Pharmaceuticals Inc stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cipher Pharmaceuticals Inc's current assets represent 17.9% of total assets in 2025, a decrease from 76.3% in 2004.
- Cash Position: Cash and equivalents constituted 4.8% of total assets in 2025, down from 46.5% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is intangible assets at 46.0% of total assets.
Cipher Pharmaceuticals Inc Competitors by Total Assets
Key competitors of Cipher Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥31.82 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
Cipher Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.59 | 1.72 | 2.58 |
| Quick Ratio | 1.11 | 1.41 | 2.43 |
| Cash Ratio | 0.00 | 0.64 | 0.00 |
| Working Capital | CA$11.45 Million | CA$12.79 Million | CA$15.06 Million |
Cipher Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between Cipher Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.92 |
| Latest Market Cap to Assets Ratio | 1.71 |
| Asset Growth Rate (YoY) | -3.9% |
| Total Assets | CA$156.22 Million |
| Market Capitalization | $267.68 Million USD |
Valuation Analysis
Above Book Valuation: The market values Cipher Pharmaceuticals Inc's assets above their book value (1.71x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Cipher Pharmaceuticals Inc's assets decreased by 3.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Cipher Pharmaceuticals Inc (2004–2025)
The table below shows the annual total assets of Cipher Pharmaceuticals Inc from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$156.22 Million ≈ $113.01 Million |
-3.87% |
| 2024-12-31 | CA$162.51 Million ≈ $117.56 Million |
+88.90% |
| 2023-12-31 | CA$86.03 Million ≈ $62.23 Million |
+16.61% |
| 2022-12-31 | CA$73.78 Million ≈ $53.37 Million |
+42.84% |
| 2021-12-31 | CA$51.65 Million ≈ $37.36 Million |
+16.66% |
| 2020-12-31 | CA$44.28 Million ≈ $32.03 Million |
-4.69% |
| 2019-12-31 | CA$46.45 Million ≈ $33.60 Million |
-16.58% |
| 2018-12-31 | CA$55.69 Million ≈ $40.28 Million |
-11.79% |
| 2017-12-31 | CA$63.13 Million ≈ $45.67 Million |
-18.44% |
| 2016-12-31 | CA$77.41 Million ≈ $55.99 Million |
-29.40% |
| 2015-12-31 | CA$109.65 Million ≈ $79.32 Million |
+884.67% |
| 2014-12-31 | CA$11.14 Million ≈ $8.06 Million |
-78.66% |
| 2013-12-31 | CA$52.17 Million ≈ $37.74 Million |
+136.40% |
| 2012-12-31 | CA$22.07 Million ≈ $15.96 Million |
+53.71% |
| 2011-12-31 | CA$14.36 Million ≈ $10.39 Million |
-11.21% |
| 2010-12-31 | CA$16.17 Million ≈ $11.70 Million |
+14.23% |
| 2009-12-31 | CA$14.16 Million ≈ $10.24 Million |
+5.20% |
| 2008-12-31 | CA$13.46 Million ≈ $9.73 Million |
-28.80% |
| 2007-12-31 | CA$18.90 Million ≈ $13.67 Million |
-2.11% |
| 2006-12-31 | CA$19.31 Million ≈ $13.97 Million |
-12.78% |
| 2005-12-31 | CA$22.14 Million ≈ $16.02 Million |
-31.59% |
| 2004-12-31 | CA$32.36 Million ≈ $23.41 Million |
-- |
About Cipher Pharmaceuticals Inc
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead… Read more